These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

271 related items for PubMed ID: 2509762

  • 1. [Properties of factor VIII/von Willebrand factor in two highly-purified factor VIII concentrates, Hemofil M and Monoclate, using monoclonal antibodies].
    Tanaka I, Yoshioka A, Shima M, Fujiwara T, Terada S, Nakai H, Miyata S, Sawamoto Y, Kamisue S, Fukui H.
    Rinsho Ketsueki; 1989 Jul; 30(7):951-7. PubMed ID: 2509762
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Comparison of two von Willebrand factor collagen-binding assays with different binding affinities for low, medium, and high multimers of von Willebrand factor.
    Neugebauer BM, Goy C, Budek I, Seitz R.
    Semin Thromb Hemost; 2002 Apr; 28(2):139-48. PubMed ID: 11992237
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Von Willebrand factor multimers in virus-inactivated plasmas and F VIII concentrates.
    Budde U, Drewke E.
    Beitr Infusionsther Transfusionsmed; 1994 Apr; 32():408-14. PubMed ID: 9422121
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Enzyme-linked immunoabsorbent assay of factor VIII-related antigen. Interest in study of Von Willerbrand's disease (author's transl)].
    Mazurier C, Parquet-Gernez A, Goudemand M.
    Pathol Biol (Paris); 1977 Dec; 25 Suppl():18-24. PubMed ID: 353655
    [Abstract] [Full Text] [Related]

  • 8. A critical evaluation of the available methods for the determination of factor VIII von Willebrand.
    Casonato A, Girolami A.
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1986 Dec; 113(5):670-84. PubMed ID: 2435633
    [Abstract] [Full Text] [Related]

  • 9. Using a monoclonal antibody to identify patients with type I and type II von Willebrand's disease.
    Hall JD, Willis DW, Evatt BL, Jackson DW.
    Thromb Haemost; 1987 Jun 03; 57(3):332-6. PubMed ID: 3116703
    [Abstract] [Full Text] [Related]

  • 10. Characterization of proteases in AHF concentrates: effect on factor VIII:von Willebrand protein as assessed by high-pressure gel permeation chromatography.
    Orthner CL.
    J Lab Clin Med; 1984 Nov 03; 104(5):816-28. PubMed ID: 6436416
    [Abstract] [Full Text] [Related]

  • 11. In vivo recovery and survival of monoclonal-antibody-purified factor VIII concentrates.
    Kasper CK, Kim HC, Gomperts ED, Smith KJ, Salzman PM, Tipping D, Miller R, Montgomery RM.
    Thromb Haemost; 1991 Dec 02; 66(6):730-3. PubMed ID: 1796419
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Monoclonal antibodies against the human factor VIII von Willebrand molecule: characterization and potential for screening of von Willebrand patients.
    Avner P, Arnaud D, Sultan Y, Maisonneuve P, Jeanneau C.
    Dev Biol Stand; 1984 Dec 02; 57():69-76. PubMed ID: 6084622
    [Abstract] [Full Text] [Related]

  • 15. Comparative analysis and classification of von Willebrand factor/factor VIII concentrates: impact on treatment of patients with von Willebrand disease.
    Budde U, Metzner HJ, Müller HG.
    Semin Thromb Hemost; 2006 Sep 02; 32(6):626-35. PubMed ID: 16977573
    [Abstract] [Full Text] [Related]

  • 16. Comparison of the pharmacokinetics of two von Willebrand factor concentrates [Biostate and AHF (High Purity)] in people with von Willebrand disorder. A randomised cross-over, multi-centre study.
    Favaloro EJ, Lloyd J, Rowell J, Baker R, Rickard K, Kershaw G, Street A, Scarff K, Barrese G, Maher D, McLachlan AJ.
    Thromb Haemost; 2007 Jun 02; 97(6):922-30. PubMed ID: 17549293
    [Abstract] [Full Text] [Related]

  • 17. A comparative in vitro evaluation of six von Willebrand factor concentrates.
    Lethagen S, Carlson M, Hillarp A.
    Haemophilia; 2004 May 02; 10(3):243-9. PubMed ID: 15086321
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. von Willebrand factor contained in factor VIII concentrates of different purities supports platelet adhesion in blood samples from a heterogeneous group of patients with von Willebrand disease.
    Escolar G, Carretero M, Magallón M, Quintana M, Arnau C, Castillo R, Aznar-Salatti J.
    Haematologica; 1998 Nov 02; 83(11):1009-14. PubMed ID: 9864923
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.